These drugs inhibit interleukin (IL)-5, while Dupixent inhibits IL-4 and IL-13, but can be considered a rival because it is also an injection. Patients may opt to take the others because of their ...

Both drugs come in prefilled single-use pens and syringes. You’ll take either drug as an injection under your skin. You may be prescribed either Ebglyss or Dupixent once every 2 or 4 weeks ...

The ADEPT trial met all primary and key secondary endpoints, enrolling 106 adults with moderate-to-severe BP who were randomized to receive Dupixent 300 mg (n=53) every two weeks after an initial ...

Regeneron Pharmaceuticals (REGN) and Sanofi (SNY) presented positive results from the pivotal ADEPT Phase 2/3 trial evaluating the investigational use of Dupixent in adults with moderate-to-severe ...

The US regulator cleared the IL-31 inhibitor as a pre-filled pen for subcutaneous injection for the treatment ... Regeneron's big-selling IL-4 and IL-13 inhibitor Dupixent (dupilumab), which ...

Five times more adults on Dupixent achieved sustained disease remission at 36 weeks compared to placebo; significant reductions were also seen in disease severity and itch Dupixent also significantly ...